Brookfield Asset Management Inc. Elanco Animal Health Inc Transaction History

Brookfield Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $2.73 Million - $7.13 Million	219,827 New	219,827 $2.73 Million
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $1.9 Million - $2.23 Million	-76,905 Reduced 56.46%	59,303 $1.55 Million
Q1 2021 May 17, 2021	SELL	$27.85 - $34.49 $509,487 - $630,960	-18,294 Reduced 11.84%	136,208 $4.01 Million
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $2.07 Million - $2.54 Million	75,308 Added 95.09%	154,502 $4.74 Million
Q3 2020 Nov 16, 2020	SELL	$21.1 - $29.13 $216,253 - $298,553	-10,249 Reduced 11.46%	79,194 $2.21 Million
Q2 2020 Aug 14, 2020	BUY	$18.94 - $24.93 $1.69 Million - $2.23 Million	89,443 New	89,443 $1.92 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.